Moderna shares soar 177% after successful trial of experimental skin cancer jab
The company said a critical late-stage study of an experimental vaccine showed the treatment stopped melanoma from spreading.
We haven't written up this one. This Is Money has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.